3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sleep Initiation and Maintenance Disorders
4
Neoplasms
4
Anxiety Disorders
4
Fatigue
3
Depression
2
Breast Neoplasms
2
Weight Loss
1
Weight Gain
1
Tobacco Use Disorder
1
Substance-Related Disorders
1
Nervous System Diseases
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Melanoma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Inflammation
1
Glioma
1
Generalized Anxiety Disorder
1
Cognitive Dysfunction
1
Chronic Pain
1
Burnout, Psychological
1
Interventions
fludarabine
6
efgartigimod alfa
6
Cyclophosphamide
6
ravulizumab
4
zilucoplan
2
telitacicept
2
rozanolixizumab
2
Prednisone
2
remibrutinib
1
iptacopan
1
inebilizumab
1
bu-zhong-yi-qi-tang
1
Walk Test
1
Tacrolimus
1
Steroids
1
Rituximab
1
Pyridostigmine Bromide
1
Prednisolone
1
Mycophenolic Acid
1
Diagnostic Self Evaluation
1
Cognitive Behavioral Therapy
1
Cladribine
1
Biomarkers
1
Azathioprine
1
Alleles
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Myasthenia Gravis
×
Cognitive Behavioral Therapy
×
Clear all
NCT06659627
2025-09-09
FIT to ACT-MG
Leiden University Medical Center
Phase NA
Recruiting
60 enrolled